RNF19B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.399000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.831000E-01
Normal-vs-Stage2
5.979800E-01
Normal-vs-Stage3
9.160400E-01
Normal-vs-Stage4
1.415440E-01
Stage1-vs-Stage2
4.407600E-01
Stage1-vs-Stage3
9.323600E-01
Stage1-vs-Stage4
1.971390E-01
Stage2-vs-Stage3
4.526000E-01
Stage2-vs-Stage4
3.246400E-01
Stage3-vs-Stage4
1.443560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.576200E-01
Normal-vs-AfricanAmerican
6.614000E-01
Normal-vs-Asian
7.940600E-01
Caucasian-vs-AfricanAmerican
9.576200E-01
Caucasian-vs-Asian
8.051800E-01
AfricanAmerican-vs-Asian
9.125000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.040000E-01
Normal-vs-Female
7.185000E-01
Male-vs-Female
4.196600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.531600E-01
Normal-vs-Age(41-60Yrs)
2.951400E-01
Normal-vs-Age(61-80Yrs)
8.374800E-01
Normal-vs-Age(81-100Yrs)
6.854400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.455800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.306400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.084600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.755410E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.845100E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.462980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.261400E-01
Normal-vs-Daily Drinker
6.280800E-01
Normal-vs-Weekly Drinker
8.116600E-01
Normal-vs-Occasional Drinker
1.510040E-01
Normal-vs-Social Drinker
7.009600E-01
Non Drinker-vs-Daily Drinker
1.905180E-01
Non Drinker-vs-Weekly Drinker
7.298400E-01
Non Drinker-vs-Occasional Drinker
1.644420E-03
Non Drinker-vs-Social Drinker
3.434800E-01
Daily Drinker-vs-Weekly Drinker
2.011000E-01
Daily Drinker-vs-Occasional Drinker
9.060300E-02
Daily Drinker-vs-Social Drinker
7.996600E-01
Weekly Drinker-vs-Occasional Drinker
6.998100E-03
Weekly Drinker-vs-Social Drinker
3.074400E-01
Occasional Drinker-vs-Social Drinker
5.973600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.364200E-01
Normal-vs-Grade 2
4.424200E-02
Normal-vs-Grade 3
2.948200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.816100E-03
Grade 1-vs-Grade 3
2.740600E-03
Grade 1-vs-Grade 4
3.364200E-01
Grade 2-vs-Grade 3
4.576800E-01
Grade 2-vs-Grade 4
4.424200E-02
Grade 3-vs-Grade 4
2.948200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.617000E-01
Normal-vs-NonDiabetic
7.136800E-01
Diabetic-vs-NonDiabetic
9.049800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.529770E-01
Normal-vs-NoPancreatitis
7.157600E-01
Pancreatitis-vs-NoPancreatitis
3.839500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.871000E-01
Normal-vs-N1
6.447800E-01
N0-vs-N1
8.652800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.630800E-01
Normal-vs-TP53-NonMutant
8.632000E-01
TP53-Mutant-vs-TP53-NonMutant
2.302000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
